| Year |
Citation |
Score |
| 2024 |
Brown BA, Myers PJ, Adair SJ, Pitarresi JR, Sah-Teli SK, Campbell LA, Hart WS, Barbeau MC, Leong K, Seyler N, Kane W, Lee KE, Stelow E, Jones M, Simon MC, ... ... Stanger BZ, et al. A histone methylation-MAPK signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreatic cancer. Cancer Research. PMID 38471099 DOI: 10.1158/0008-5472.CAN-22-2945 |
0.31 |
|
| 2024 |
Katsuda T, Sussman JH, Ito K, Katznelson A, Yuan S, Takenaka N, Li J, Merrell AJ, Cure H, Li Q, Rasool RU, Asangani IA, Zaret KS, Stanger BZ. Cellular reprogramming in vivo initiated by SOX4 pioneer factor activity. Nature Communications. 15: 1761. PMID 38409161 DOI: 10.1038/s41467-024-45939-z |
0.3 |
|
| 2024 |
Kim IK, Diamond MS, Yuan S, Kemp SB, Kahn BM, Li Q, Lin JH, Li J, Norgard RJ, Thomas SK, Merolle M, Katsuda T, Tobias JW, Baslan T, Politi K, ... ... Stanger BZ, et al. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma. Nature Communications. 15: 1532. PMID 38378697 DOI: 10.1038/s41467-024-46048-7 |
0.307 |
|
| 2023 |
Pitarresi JR, Stanger BZ. Cellular Origins and Lineage Plasticity in Cancer. Cold Spring Harbor Perspectives in Medicine. PMID 37604590 DOI: 10.1101/cshperspect.a041389 |
0.328 |
|
| 2023 |
Sussman JH, Stanger BZ. Digging deeper into the early steps of cancer progression. Trends in Cancer. PMID 37495432 DOI: 10.1016/j.trecan.2023.07.003 |
0.313 |
|
| 2023 |
Kim IK, Diamond M, Yuan S, Kemp S, Li Q, Lin J, Li J, Norgard R, Thomas S, Merolle M, Katsuda T, Tobias J, Politi K, Vonderheide R, Stanger B. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy. Research Square. PMID 37398248 DOI: 10.21203/rs.3.rs-2960521/v1 |
0.319 |
|
| 2023 |
Bianchi A, De Castro Silva I, Deshpande NU, Singh S, Mehra S, Garrido VT, Guo X, Nivelo LA, Kolonias DS, Saigh SJ, Wieder E, Rafie CI, Dosch AR, Zhou Z, Umland O, ... ... Stanger BZ, et al. Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer. Cancer Discovery. PMID 36946782 DOI: 10.1158/2159-8290.CD-22-1046 |
0.343 |
|
| 2023 |
Katsuda T, Sussman J, Ito K, Katznelson A, Yuan S, Li J, Merrell AJ, Takenaka N, Cure H, Li Q, Rasool RU, Asangani IA, Zaret KS, Stanger BZ. Physiological reprogramming mediated by Sox4 pioneer factor activity. Biorxiv : the Preprint Server For Biology. PMID 36824858 DOI: 10.1101/2023.02.14.528556 |
0.302 |
|
| 2022 |
Halbrook CJ, Thurston G, Boyer S, Anaraki C, Jiménez JA, McCarthy A, Steele NG, Kerk SA, Hong HS, Lin L, Law FV, Felton C, Scipioni L, Sajjakulnukit P, Andren A, ... ... Stanger BZ, et al. Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Nature Cancer. 3: 1386-1403. PMID 36411320 DOI: 10.1038/s43018-022-00463-1 |
0.305 |
|
| 2022 |
McBrearty N, Cho C, Chen J, Zahedi F, Peck AR, Radaelli E, Assenmacher CA, Pavlak C, Devine A, Yu P, Lu Z, Zhang H, Li J, Pitarresi JR, Astsaturov I, ... ... Stanger BZ, et al. Tumor suppressive and immune-stimulating roles of cholesterol 25-hydroxylase in pancreatic cancer cells. Molecular Cancer Research : McR. PMID 36378658 DOI: 10.1158/1541-7786.MCR-22-0602 |
0.332 |
|
| 2022 |
Zhang Y, Xu Y, Lu W, Li J, Yu S, Brown EJ, Stanger BZ, Rabinowitz JD, Yang X. G6PD-mediated increase in de novo NADP biosynthesis promotes antioxidant defense and tumor metastasis. Science Advances. 8: eabo0404. PMID 35857842 DOI: 10.1126/sciadv.abo0404 |
0.332 |
|
| 2022 |
Sela Y, Li J, Maheswaran S, Norgard RJ, Yuan S, Hubbi ME, Doepner M, Xu JP, Ho ES, Mesaros C, Sheehan C, Croley G, Muir A, Blair IA, Shalem O, ... ... Stanger BZ, et al. Bcl-xL enforces a slow-cycling state necessary for survival in the nutrient-deprived microenvironment of pancreatic cancer. Cancer Research. PMID 35315913 DOI: 10.1158/0008-5472.CAN-22-0431 |
0.301 |
|
| 2021 |
Maddipati R, Norgard RJ, Baslan T, Rathi KS, Zhang A, Saeid A, Higashihara T, Wu F, Kumar A, Annamalai V, Bhattacharya S, Raman P, Adkisson CA, Pitarresi JR, Wengyn MD, ... ... Stanger BZ, et al. MYC levels regulate metastatic heterogeneity in pancreatic adenocarcinoma. Cancer Discovery. PMID 34551968 DOI: 10.1158/2159-8290.CD-20-1826 |
0.773 |
|
| 2021 |
Norgard RJ, Pitarresi JR, Maddipati R, Aiello-Couzo NM, Balli D, Li J, Yamazoe T, Wengyn MD, Millstein ID, Folkert IW, Rosario-Berrios DN, Kim IK, Bassett JB, Payne R, Berry CT, ... ... Stanger BZ, et al. Calcium signaling induces a partial EMT. Embo Reports. e51872. PMID 34324787 DOI: 10.15252/embr.202051872 |
0.767 |
|
| 2021 |
Simeonov KP, Byrns CN, Clark ML, Norgard RJ, Martin B, Stanger BZ, Shendure J, McKenna A, Lengner CJ. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer Cell. PMID 34115987 DOI: 10.1016/j.ccell.2021.05.005 |
0.308 |
|
| 2021 |
Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, Filliol A, Chin L, Savage TM, Yin D, Wirsik NM, Mehal A, Arpaia N, Seki E, Mack M, ... ... Stanger BZ, et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. The Journal of Clinical Investigation. PMID 33905375 DOI: 10.1172/JCI146987 |
0.308 |
|
| 2021 |
Pitarresi JR, Norgard RJ, Chiarella AM, Suzuki K, Bakir B, Sahu V, Li J, Zhao J, Marchand B, Wengyn MD, Hsieh A, Kim IK, Zhang A, Sellin K, Lee V, ... ... Stanger BZ, et al. PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability. Cancer Discovery. PMID 33589425 DOI: 10.1158/2159-8290.CD-20-1098 |
0.338 |
|
| 2021 |
Norgard RJ, Stanger BZ. Isolation and Identification of EMT Subtypes. Methods in Molecular Biology (Clifton, N.J.). 2179: 315-326. PMID 32939730 DOI: 10.1007/978-1-0716-0779-4_24 |
0.471 |
|
| 2020 |
Li J, Yuan S, Norgard RJ, Yan F, Sun YH, Kim IK, Merrell AJ, Sela Y, Jiang Y, Bhanu NV, Garcia BA, Vonderheide RH, Blanco A, Stanger BZ. Epigenetic and transcriptional control of the epidermal growth factor receptor (EGFR) regulates the tumor immune microenvironment in pancreatic cancer. Cancer Discovery. PMID 33158848 DOI: 10.1158/2159-8290.CD-20-0519 |
0.3 |
|
| 2020 |
Li J, Stanger BZ. Cell Cycle Regulation Meets Tumor Immunosuppression. Trends in Immunology. PMID 32800703 DOI: 10.1016/J.It.2020.07.010 |
0.423 |
|
| 2020 |
Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, Mark MT, Steiner L, Benito-Martin A, Lucotti S, Di Giannatale A, ... ... Stanger BZ, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. PMID 32795414 DOI: 10.1016/J.Cell.2020.07.009 |
0.325 |
|
| 2020 |
Li J, Stanger BZ. How Tumor Cell Dedifferentiation Drives Immune Evasion And Resistance to Immunotherapy. Cancer Research. PMID 32554552 DOI: 10.1158/0008-5472.Can-20-1420 |
0.372 |
|
| 2020 |
Natale CA, Li J, Pitarresi JR, Norgard RJ, Dentchev T, Capell BC, Seykora JT, Stanger BZ, Ridky TW. Pharmacologic activation of the G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma. Cellular and Molecular Gastroenterology and Hepatology. PMID 32376419 DOI: 10.1016/J.Jcmgh.2020.04.016 |
0.311 |
|
| 2020 |
Chandrakesan P, Panneerselvam J, May R, Weygant N, Qu D, Berry WR, Pitts K, Stanger BZ, Rao CV, Bronze MS, Houchen CW. DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization. Molecular Cancer Therapeutics. PMID 32371580 DOI: 10.1158/1535-7163.Mct-19-0776 |
0.361 |
|
| 2020 |
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, García de Herreros A, ... ... Stanger B, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nature Reviews. Molecular Cell Biology. PMID 32300252 DOI: 10.1038/S41580-020-0237-9 |
0.328 |
|
| 2020 |
Ruscetti M, Morris JP, Mezzadra R, Russell J, Leibold J, Romesser PB, Simon J, Kulick A, Ho YJ, Fennell M, Li J, Norgard RJ, Wilkinson JE, Alonso-Curbelo D, Sridharan R, ... ... Stanger BZ, et al. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell. PMID 32234521 DOI: 10.1016/J.Cell.2020.03.008 |
0.422 |
|
| 2020 |
Yuan S, Natesan R, Sanchez-Rivera FJ, Li J, Bhanu NV, Yamazoe T, Lin JH, Merrell AJ, Sela Y, Thomas SK, Jiang Y, Plesset JB, Miller EM, Shi J, Garcia BA, ... ... Stanger BZ, et al. Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression. Cancer Discovery. PMID 32188706 DOI: 10.1158/2159-8290.Cd-19-1299 |
0.405 |
|
| 2020 |
Cardenas-Diaz FL, Leavens KF, Kishore S, Osorio-Quintero C, Chen YJ, Stanger BZ, Wang P, French D, Gadue P. A dual reporter EndoC-βH1 human β-cell line for efficient quantification of calcium flux and insulin secretion. Endocrinology. PMID 31960055 DOI: 10.1210/Endocr/Bqaa005 |
0.336 |
|
| 2020 |
Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin J, Sun YH, Liudahl SM, Tobias JW, Lowe S, Coussens LM, Wherry JE, Vonderheide RH, ... Stanger BZ, et al. Abstract PR11: Tumor cell-intrinsic factors underlie the heterogeneity of immune infiltration and response to immunotherapy in pancreatic cancer Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-Pr11 |
0.436 |
|
| 2019 |
Li J, Yuan S, Norgard RJ, Yan F, Yamazoe T, Blanco A, Stanger BZ. Tumor cell-intrinsic USP22 suppresses antitumor immunity in pancreatic cancer. Cancer Immunology Research. PMID 31871120 DOI: 10.1158/2326-6066.Cir-19-0661 |
0.461 |
|
| 2019 |
Nguyen DT, Lee E, Alimperti S, Norgard RJ, Wong A, Lee JJ, Eyckmans J, Stanger BZ, Chen CS. A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. Science Advances. 5: eaav6789. PMID 31489365 DOI: 10.1126/Sciadv.Aav6789 |
0.386 |
|
| 2019 |
Mills JC, Stanger BZ, Sander M. Nomenclature for cellular plasticity: are the terms as plastic as the cells themselves? The Embo Journal. e103148. PMID 31475380 DOI: 10.15252/Embj.2019103148 |
0.355 |
|
| 2019 |
Qu D, Weygant N, Yao J, Chandrakesan P, Berry WL, May R, Pitts K, Husain S, Lightfoot S, Li M, Wang TC, An G, Clendenin C, Stanger BZ, Houchen CW. Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer. Journal of Oncology. 2019: 6402925. PMID 31467540 DOI: 10.1155/2019/6402925 |
0.413 |
|
| 2019 |
Braitsch CM, Azizoglu DB, Htike Y, Barlow HR, Schnell U, Chaney CP, Carroll TJ, Stanger BZ, Cleaver O. LATS1/2 suppress NFκB and aberrant EMT initiation to permit pancreatic progenitor differentiation. Plos Biology. 17: e3000382. PMID 31323030 DOI: 10.1371/Journal.Pbio.3000382 |
0.474 |
|
| 2019 |
Markosyan N, Li J, Sun YH, Richman LP, Lin JH, Yan F, Quinones L, Sela Y, Yamazoe T, Gordon N, Tobias JW, Byrne KT, Rech AJ, FitzGerald GA, Stanger BZ, et al. Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2). The Journal of Clinical Investigation. 130. PMID 31162144 DOI: 10.1172/Jci127755 |
0.424 |
|
| 2019 |
McDonald PC, Chafe SC, Brown WS, Saberi S, Swayampakula M, Venkateswaran G, Nemirovsky O, Gillespie JA, Karasinska JM, Kalloger SE, Supuran CT, Schaeffer DF, Bashashati A, Shah SP, Topham JT, ... ... Stanger BZ, et al. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. Gastroenterology. PMID 31078621 DOI: 10.1053/J.Gastro.2019.05.004 |
0.349 |
|
| 2019 |
Yuan S, Norgard RJ, Stanger BZ. Cellular Plasticity in Cancer. Cancer Discovery. PMID 30992279 DOI: 10.1158/2159-8290.Cd-19-0015 |
0.429 |
|
| 2019 |
Li J, Stanger BZ. The tumor as organizer model. Science (New York, N.Y.). 363: 1038-1039. PMID 30846584 DOI: 10.1126/Science.Aau9861 |
0.308 |
|
| 2019 |
Carrer A, Trefely S, Zhao S, Campbell S, Norgard RJ, Schultz KC, Sidoli S, Parris JLD, Affronti HC, Sivanand S, Egolf S, Sela Y, Trizzino M, Gardini A, Garcia BA, ... ... Stanger BZ, et al. Acetyl-CoA metabolism supports multi-step pancreatic tumorigenesis. Cancer Discovery. PMID 30626590 DOI: 10.1158/2159-8290.Cd-18-0567 |
0.302 |
|
| 2019 |
Byrne KT, Li J, Vonderheide RH, Stanger B. Abstract A054: Tumor cell intrinsic factors dictate immune cell infiltration and response to immunotherapy Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A054 |
0.399 |
|
| 2019 |
Ruscetti M, Morris JP, Mezzadra R, Russell J, Leibold J, Romesser PB, Simon J, Kulick A, Ho Y, Fennell M, Li J, Norgard RJ, Wilkinson JE, Alonso-Curbelo D, Sridharan R, ... ... Stanger BZ, et al. Abstract PR01: Senescence induction triggers vascular remodeling and new vulnerabilities to chemo- and immunotherapy in pancreas cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-Pr01 |
0.406 |
|
| 2019 |
Sela Y, Li J, Doepner M, Maheswaran S, Mesaros C, Blair I, Shalem O, Stanger B. Abstract C50: Dissecting vulnerabilities of pancreatic tumors’ silent fraction unravels secrets of an alternative cell state Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-C50 |
0.467 |
|
| 2019 |
Clendenin C, Sor R, McMenamin D, Stanger BZ, Beatty G, Vonderheide RH. Abstract C13: A “mouse hospital” for preclinical testing of diagnostic and treatment modalities in pancreatic ductal adenocarcinoma (PDA) Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-C13 |
0.405 |
|
| 2019 |
Pitarresi JR, Norgard RJ, Stanger BZ, Rustgi AK. Abstract B43: p120 catenin loss drives pancreatic cancer EMT and metastasis through activation of PTHrP-mediated calcium signaling Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B43 |
0.461 |
|
| 2019 |
Norgard RJ, Maddipati R, Aiello NM, Balli D, Pitarresi JR, Rosario-Berrios DN, Li J, Yuan S, Yamazoe T, Sela Y, Merrell AJ, Wengyn MD, Sun K, Rustgi AK, Stanger BZ. Abstract B38: Calcium signaling induces a partial EMT in pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B38 |
0.483 |
|
| 2019 |
Markosyan N, Li J, Sun Y, Richman L, Lin J, Yan F, Quinones L, Sela Y, Yamazoe T, Gordon N, Tobias J, Byrne K, Rech A, FitzGerald G, Stanger B, et al. Abstract B33: Tumor cell-intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2) in pancreatic adenocarcinoma Immunotherapy. 79. DOI: 10.1158/1538-7445.Panca19-B33 |
0.442 |
|
| 2019 |
Natale C, Li J, Dentchev T, Capell B, Seykora J, Stanger B, Ridky T. Abstract B21: Pharmacologic activation of G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B21 |
0.392 |
|
| 2019 |
Yuan S, Natesan R, Sanchez-Rivera FJ, Li J, Bhanu NV, Yamazoe T, Lin JH, Merrell AJ, Thomas SK, Shi J, Garcia BA, Lowe SW, Asangani IA, Stanger BZ. Abstract A59: CRISPR screen identifies global regulation of H3K36me2 as an epigenomic mechanism underlying epithelial plasticity in pancreatic ductal adenocarcinoma Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A59 |
0.433 |
|
| 2019 |
Li J, Byrne KT, Markosyan N, Yamazoe T, Yan F, Chen Z, Sun YH, Lin J, Sela Y, Norgard RJ, Yuan S, Merrell AJ, Tobias JW, Vonderheide RH, Stanger BZ. Abstract A28: Investigation of tumor-cell-intrinsic factors regulating immune infiltration and response to immunotherapy in pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A28 |
0.44 |
|
| 2019 |
Carrer A, Trefely S, Zhao S, Campbell S, Sela Y, Sidoli S, Garcia BA, Snyder NW, Stanger BZ, Wellen KE. Abstract A03: All the roads bring to Rome: How acetyl-CoA metabolism supports multistep pancreatic carcinogenesis Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A03 |
0.439 |
|
| 2018 |
Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin JH, Sun YH, Rech AJ, Balli D, Hay CA, Sela Y, Merrell AJ, Liudahl SM, ... ... Stanger BZ, et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity. PMID 29958801 DOI: 10.1016/J.Immuni.2018.06.006 |
0.42 |
|
| 2018 |
Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, Yamazoe T, Black T, Sahmoud A, Furth EE, Bar-Sagi D, Stanger BZ. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Developmental Cell. 45: 681-695.e4. PMID 29920274 DOI: 10.1016/J.Devcel.2018.05.027 |
0.779 |
|
| 2018 |
Bhagwat N, Dulmage K, Pletcher CH, Wang L, DeMuth W, Sen M, Balli D, Yee SS, Sa S, Tong F, Yu L, Moore JS, Stanger BZ, Dixon EP, Carpenter EL. An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters. Scientific Reports. 8: 5035. PMID 29568081 DOI: 10.1038/S41598-018-23217-5 |
0.409 |
|
| 2018 |
Rech AJ, Balli D, Mantero A, Ishwaran H, Nathanson KL, Stanger BZ, Vonderheide RH. Tumor immunity and survival as a function of alternative neopeptides in human cancer. Cancer Immunology Research. PMID 29339376 DOI: 10.1158/2326-6066.Cir-17-0559 |
0.349 |
|
| 2018 |
Natale CA, Li J, Zhang J, Dahal A, Dentchev T, Stanger BZ, Ridky TW. Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade. Elife. 7. PMID 29336307 DOI: 10.7554/Elife.31770 |
0.399 |
|
| 2018 |
Byrne KT, Li J, Vonderheide RH, Stanger BZ. Abstract 1011: Tumor cell intrinsic factors dictate T cell infiltration and therapeutic response in pancreatic ductal adenocarcinoma Tumor Biology. DOI: 10.1158/1538-7445.Am2018-1011 |
0.419 |
|
| 2018 |
Natale CA, Li J, Zhang J, Dahal A, Stanger B, Ridky T. Abstract B053: GPER signaling inhibits melanoma and improves response to PD-1 blockade Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B053 |
0.349 |
|
| 2017 |
Ko J, Bhagwat N, Yee SS, Ortiz N, Sahmoud A, Black T, Aiello NM, McKenzie L, O'Hara M, Redlinger C, Romeo J, Carpenter EL, Stanger BZ, Issadore D. Combining Machine Learning and Nanofluidic Technology to Diagnose Pancreatic Cancer Using Exosomes. Acs Nano. PMID 29019651 DOI: 10.1021/Acsnano.7B05503 |
0.327 |
|
| 2017 |
Ko J, Bhagwat N, Yee SS, Black T, Redlinger C, Romeo J, O'Hara M, Raj A, Carpenter EL, Stanger BZ, Issadore D. A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysis. Lab On a Chip. PMID 28809985 DOI: 10.1039/C7Lc00703E |
0.363 |
|
| 2017 |
Aiello NM, Brabletz T, Kang Y, Nieto MA, Weinberg RA, Stanger BZ. Upholding a role for EMT in pancreatic cancer metastasis. Nature. 547: E7-E8. PMID 28682339 DOI: 10.1038/Nature22963 |
0.367 |
|
| 2017 |
Bhagwat N, Pletcher CH, Wang L, DeMuth W, Dulmage K, Balli D, Yee SS, Yu L, Moore JS, Stanger BZ, Dixon EP, Carpenter EL. Abstract 3801: A novel sensitive flow-cytometry based platform for isolation and molecular characterization of circulating tumor single cells and clusters Cancer Research. 77: 3801-3801. DOI: 10.1158/1538-7445.Am2017-3801 |
0.414 |
|
| 2016 |
Balli D, Rech AJ, Stanger BZ, Vonderheide RH. Immune cytolytic activity stratifies molecular subsets of human pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28007776 DOI: 10.1158/1078-0432.Ccr-16-2128 |
0.314 |
|
| 2016 |
Evans RA, Diamond MS, Rech AJ, Chao T, Richardson MW, Lin JH, Bajor DL, Byrne KT, Stanger BZ, Riley JL, Markosyan N, Winograd R, Vonderheide RH. Lack of immunoediting in murine pancreatic cancer reversed with neoantigen. Jci Insight. 1. PMID 27642636 DOI: 10.1172/Jci.Insight.88328 |
0.379 |
|
| 2016 |
Aiello NM, Bajor DL, Norgard RJ, Sahmoud A, Bhagwat N, Pham MN, Cornish TC, Iacobuzio-Donahue CA, Vonderheide RH, Stanger BZ. Metastatic progression is associated with dynamic changes in the local microenvironment. Nature Communications. 7: 12819. PMID 27628423 DOI: 10.1038/Ncomms12819 |
0.369 |
|
| 2016 |
Yi J, Lu L, Yanger K, Wang W, Hwa Sohn B, Stanger BZ, Zhang M, Martin JF, Ajani JA, Chen J, Lee JS, Song S, Johnson RL. LATS1 and LATS2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Hepatology (Baltimore, Md.). PMID 27531557 DOI: 10.1002/Hep.28768 |
0.43 |
|
| 2016 |
Merrell AJ, Stanger BZ. Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style. Nature Reviews. Molecular Cell Biology. PMID 26979497 DOI: 10.1038/Nrm.2016.24 |
0.379 |
|
| 2016 |
Ariyachet C, Tovaglieri A, Xiang G, Lu J, Shah MS, Richmond CA, Verbeke C, Melton DA, Stanger BZ, Mooney D, Shivdasani RA, Mahony S, Xia Q, Breault DT, Zhou Q. Reprogrammed Stomach Tissue as a Renewable Source of Functional β Cells for Blood Glucose Regulation. Cell Stem Cell. PMID 26908146 DOI: 10.1016/J.Stem.2016.01.003 |
0.366 |
|
| 2016 |
Aiello NM, Stanger BZ. Echoes of the embryo: using the developmental biology toolkit to study cancer. Disease Models & Mechanisms. 9: 105-14. PMID 26839398 DOI: 10.1242/Dmm.023184 |
0.394 |
|
| 2016 |
Aiello NM, Rhim AD, Stanger BZ. Orthotopic Injection of Pancreatic Cancer Cells. Cold Spring Harbor Protocols. 2016: pdb.prot078360. PMID 26729902 DOI: 10.1101/Pdb.Prot078360 |
0.398 |
|
| 2016 |
Aiello NM, Rhim AD, Stanger BZ. Isolating Epithelial and Epithelial-to-Mesenchymal Transition Populations from Primary Tumors by Fluorescence-Activated Cell Sorting. Cold Spring Harbor Protocols. 2016: pdb.prot078352. PMID 26729901 DOI: 10.1101/Pdb.Prot078352 |
0.436 |
|
| 2016 |
Balli D, Aiello N, Norgard R, Li J, Sahmoud A, Stanger B. Abstract B10: Transcriptome analysis of mouse PDA subtypes Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-B10 |
0.445 |
|
| 2016 |
Balli D, Rech AJ, Stanger BZ, Vonderheide RH. Abstract IA23: Immune landscape of human pancreatic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-Ia23 |
0.361 |
|
| 2016 |
Stanger BZ. Abstract IA18: Probing tumor heterogeneity with mouse models Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-Ia18 |
0.329 |
|
| 2016 |
Carrer A, Lee JV, Shah S, Aiello NM, Snyder NW, Worth AJ, Blair IA, Stanger BZ, Wellen KE. Abstract PR03: Exploring the link between Kras and histone acetylation Cancer Research. 76. DOI: 10.1158/1538-7445.Chromepi15-Pr03 |
0.377 |
|
| 2016 |
McDonald PC, Chafe SC, Vallejo M, Schaeffer D, Yapp D, Supuran CT, Stanger B, Parmar M, Renouf D, Dedhar S. Abstract 754: Targeting carbonic anhydrase IX in multiple pancreatic ductal adenocarcinoma models results in tumor growth inhibition and increased survival Cancer Research. 76: 754-754. DOI: 10.1158/1538-7445.Am2016-754 |
0.449 |
|
| 2016 |
Aiello NM, Balli D, Norgard R, Li J, Sahmoud A, Stanger BZ. Abstract 2676: Epithelial-mesenchymal transition does not require transcriptional repression of the epithelial programin vivo Cancer Research. 76: 2676-2676. DOI: 10.1158/1538-7445.Am2016-2676 |
0.467 |
|
| 2015 |
Ghanem LR, Kromer A, Silverman IM, Chatterji P, Traxler E, Penzo-Mendez A, Weiss MJ, Stanger BZ, Liebhaber SA. The Poly(C) Binding Protein Pcbp2 and Its Retrotransposed Derivative Pcbp1 Are Independently Essential to Mouse Development. Molecular and Cellular Biology. 36: 304-19. PMID 26527618 DOI: 10.1128/Mcb.00936-15 |
0.307 |
|
| 2015 |
Stanger BZ. Probing hepatocyte heterogeneity. Cell Research. 25: 1181-2. PMID 26403190 DOI: 10.1038/Cr.2015.117 |
0.415 |
|
| 2015 |
Maddipati R, Stanger BZ. Pancreatic Cancer Metastases Harbor Evidence of Polyclonality. Cancer Discovery. 5: 1086-97. PMID 26209539 DOI: 10.1158/2159-8290.Cd-15-0120 |
0.772 |
|
| 2015 |
Penzo-Méndez AI, Chen YJ, Li J, Witze ES, Stanger BZ. Spontaneous Cell Competition in Immortalized Mammalian Cell Lines. Plos One. 10: e0132437. PMID 26200654 DOI: 10.1371/Journal.Pone.0132437 |
0.374 |
|
| 2015 |
Spaeth JM, Hunter CS, Bonatakis L, Guo M, French CA, Slack I, Hara M, Fisher SE, Ferrer J, Morrisey EE, Stanger BZ, Stein R. The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice. Diabetologia. PMID 26021489 DOI: 10.1007/S00125-015-3635-3 |
0.378 |
|
| 2015 |
Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, ... ... Stanger BZ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology. 17: 816-26. PMID 25985394 DOI: 10.1038/Ncb3169 |
0.405 |
|
| 2015 |
Qu D, Johnson J, Chandrakesan P, Weygant N, May R, Aiello N, Rhim A, Zhao L, Zheng W, Lightfoot S, Pant S, Irvan J, Postier R, Hocker J, Hanas JS, ... ... Stanger B, et al. Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. Plos One. 10: e0118933. PMID 25723399 DOI: 10.1371/Journal.Pone.0118933 |
0.471 |
|
| 2015 |
Winograd R, Byrne KT, Evans RA, Odorizzi PM, Meyer AR, Bajor DL, Clendenin C, Stanger BZ, Furth EE, Wherry EJ, Vonderheide RH. Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma. Cancer Immunology Research. 3: 399-411. PMID 25678581 DOI: 10.1158/2326-6066.Cir-14-0215 |
0.384 |
|
| 2015 |
Stanger BZ. Cellular homeostasis and repair in the mammalian liver. Annual Review of Physiology. 77: 179-200. PMID 25668020 DOI: 10.1146/Annurev-Physiol-021113-170255 |
0.346 |
|
| 2015 |
Shen Z, Stanger BZ. YAP regulates S-phase entry in endothelial cells. Plos One. 10: e0117522. PMID 25635998 DOI: 10.1371/Journal.Pone.0117522 |
0.562 |
|
| 2015 |
Penzo-Méndez AI, Chen Y, Li J, Witze ES, Stanger BZ. Differences in energy metabolism drive cell competition in mammalian cells. Plos One. DOI: 10.1371/Journal.Pone.0132437.G005 |
0.31 |
|
| 2015 |
Carrer A, Lee JV, Shah S, Snyder NW, Jackson E, Aiello NM, Garcia BA, Chodosh LA, Stanger BZ, Blair IA, Wellen KE. Abstract B40: Oncogenic Kras induces histone acetylation in pancreatic ductal adenocarcinoma Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B40 |
0.367 |
|
| 2015 |
Aiello NM, Bajor DL, Pham MN, Vonderheide RH, Stanger BZ. Abstract 5176: Chemotherapy alters the natural history of metastatic progression Cancer Research. 75: 5176-5176. DOI: 10.1158/1538-7445.Am2015-5176 |
0.406 |
|
| 2015 |
Maddipati R, Stanger BZ. Abstract 4135: A polyclonal origin for pancreatic cancer metastases Cancer Research. 75: 4135-4135. DOI: 10.1158/1538-7445.Am2015-4135 |
0.338 |
|
| 2015 |
Ko JA, Bhagwat N, Yee SS, Carpenter E, Stanger B, Issadore D. Abstract 386: Rapid in situ RNA analysis of circulating tumor cells using magnetic micropore-based sorting and Turbo FISH Cancer Research. 75: 386-386. DOI: 10.1158/1538-7445.Am2015-386 |
0.401 |
|
| 2015 |
Dedhia PH, Finkbeiner SR, Altheim CH, Chen Y, Stanger BZ, Wolforth JB, Teitelbaum DH, Spence JR. Generation of Functional Insulin-Producing Cells from Pluipotent Stem Cell-Derived Human Intestinal Tissue Journal of the American College of Surgeons. 221: S157. DOI: 10.1016/J.Jamcollsurg.2015.07.375 |
0.325 |
|
| 2014 |
Penzo-Méndez AI, Stanger BZ. Cell competition in vertebrate organ size regulation. Wiley Interdisciplinary Reviews. Developmental Biology. 3: 419-27. PMID 25176591 DOI: 10.1002/Wdev.148 |
0.417 |
|
| 2014 |
Yanger K, Knigin D, Zong Y, Maggs L, Gu G, Akiyama H, Pikarsky E, Stanger BZ. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell. 15: 340-9. PMID 25130492 DOI: 10.1016/J.Stem.2014.06.003 |
0.598 |
|
| 2014 |
Lee JV, Carrer A, Shah S, Snyder NW, Wei S, Venneti S, Worth AJ, Yuan ZF, Lim HW, Liu S, Jackson E, Aiello NM, Haas NB, Rebbeck TR, Judkins A, ... ... Stanger BZ, et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metabolism. 20: 306-19. PMID 24998913 DOI: 10.1016/J.Cmet.2014.06.004 |
0.349 |
|
| 2014 |
Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD. Hippo pathway activity influences liver cell fate. Cell. 157: 1324-38. PMID 24906150 DOI: 10.1016/J.Cell.2014.03.060 |
0.453 |
|
| 2014 |
Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, Dekleva EN, Saunders T, Becerra CP, Tattersall IW, Westphalen CB, Kitajewski J, Fernandez-Barrena MG, Fernandez-Zapico ME, Iacobuzio-Donahue C, ... ... Stanger BZ, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 25: 735-47. PMID 24856585 DOI: 10.1016/J.Ccr.2014.04.021 |
0.404 |
|
| 2014 |
Wang T, Yanger K, Stanger BZ, Cassio D, Bi E. Cytokinesis defines a spatial landmark for hepatocyte polarization and apical lumen formation. Journal of Cell Science. 127: 2483-92. PMID 24706948 DOI: 10.1242/Jcs.139923 |
0.347 |
|
| 2014 |
Yanger K, Stanger BZ. Liver cell reprogramming: parallels with iPSC biology. Cell Cycle (Georgetown, Tex.). 13: 1211-2. PMID 24621496 DOI: 10.4161/Cc.28381 |
0.449 |
|
| 2014 |
Chen YJ, Finkbeiner SR, Weinblatt D, Emmett MJ, Tameire F, Yousefi M, Yang C, Maehr R, Zhou Q, Shemer R, Dor Y, Li C, Spence JR, Stanger BZ. De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts. Cell Reports. 6: 1046-58. PMID 24613355 DOI: 10.1016/J.Celrep.2014.02.013 |
0.371 |
|
| 2014 |
Gao T, McKenna B, Li C, Reichert M, Nguyen J, Singh T, Yang C, Pannikar A, Doliba N, Zhang T, Stoffers DA, Edlund H, Matschinsky F, Stein R, Stanger BZ. Pdx1 maintains β cell identity and function by repressing an α cell program. Cell Metabolism. 19: 259-71. PMID 24506867 DOI: 10.1016/J.Cmet.2013.12.002 |
0.368 |
|
| 2014 |
Rhim AD, Thege FI, Santana SM, Lannin TB, Saha TN, Tsai S, Maggs LR, Kochman ML, Ginsberg GG, Lieb JG, Chandrasekhara V, Drebin JA, Ahmad N, Yang YX, Kirby BJ, ... Stanger BZ, et al. Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. Gastroenterology. 146: 647-51. PMID 24333829 DOI: 10.1053/J.Gastro.2013.12.007 |
0.423 |
|
| 2014 |
Takano S, Reichert M, Heeg S, Bakir B, Das KK, Rhim AD, Yoshitomi H, Stanger B, Rustgi AK. Tu1665 Prrx1a and Prrx1b Differentially Regulate Invasion and Metastasis in Pancreatic Cancer Gastroenterology. 146: S-813. DOI: 10.1016/S0016-5085(14)62941-3 |
0.393 |
|
| 2013 |
Zheng R, Rebolledo-Jaramillo B, Zong Y, Wang L, Russo P, Hancock W, Stanger BZ, Hardison RC, Blobel GA. Function of GATA factors in the adult mouse liver. Plos One. 8: e83723. PMID 24367609 DOI: 10.1371/Journal.Pone.0083723 |
0.568 |
|
| 2013 |
Madison BB, Liu Q, Zhong X, Hahn CM, Lin N, Emmett MJ, Stanger BZ, Lee JS, Rustgi AK. LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7. Genes & Development. 27: 2233-45. PMID 24142874 DOI: 10.1101/Gad.224659.113 |
0.356 |
|
| 2013 |
Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Research. 73: 6359-74. PMID 24097820 DOI: 10.1158/0008-5472.Can-13-1558-T |
0.374 |
|
| 2013 |
Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, Liu Q, Shimono A, Sudol M, Holmgren L, Stanger BZ, Kissil JL. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Science Signaling. 6: ra77. PMID 24003254 DOI: 10.1126/Scisignal.2004060 |
0.556 |
|
| 2013 |
Stanger BZ, Kahn ML. Platelets and tumor cells: a new form of border control. Cancer Cell. 24: 9-11. PMID 23845439 DOI: 10.1016/J.Ccr.2013.06.009 |
0.41 |
|
| 2013 |
Kim J, Hoffman JP, Alpaugh RK, Rhim AD, Rhimm AD, Reichert M, Stanger BZ, Furth EE, Sepulveda AR, Yuan CX, Won KJ, Donahue G, Sands J, Gumbs AA, Zaret KS. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Reports. 3: 2088-99. PMID 23791528 DOI: 10.1016/J.Celrep.2013.05.036 |
0.416 |
|
| 2013 |
Stanger BZ, Hebrok M. Control of cell identity in pancreas development and regeneration. Gastroenterology. 144: 1170-9. PMID 23622126 DOI: 10.1053/J.Gastro.2013.01.074 |
0.382 |
|
| 2013 |
Yanger K, Zong Y, Maggs LR, Shapira SN, Maddipati R, Aiello NM, Thung SN, Wells RG, Greenbaum LE, Stanger BZ. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes & Development. 27: 719-24. PMID 23520387 DOI: 10.1101/Gad.207803.112 |
0.619 |
|
| 2013 |
Gao T, Zhou D, Yang C, Singh T, Penzo-Méndez A, Maddipati R, Tzatsos A, Bardeesy N, Avruch J, Stanger BZ. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology. 144: 1543-53, 1553.e1. PMID 23454691 DOI: 10.1053/J.Gastro.2013.02.037 |
0.765 |
|
| 2013 |
Reichert M, Takano S, von Burstin J, Kim SB, Lee JS, Ihida-Stansbury K, Hahn C, Heeg S, Schneider G, Rhim AD, Stanger BZ, Rustgi AK. The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes & Development. 27: 288-300. PMID 23355395 DOI: 10.1101/Gad.204453.112 |
0.441 |
|
| 2013 |
Aiello NM, Bajor DL, Vonderheide RH, Stanger BZ. Abstract PR14: Lineage labeling elucidates the natural history of metastatic colonization Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Pr14 |
0.446 |
|
| 2013 |
Madison B, Liu Q, Zhong X, Hahn CM, Lin N, Emmet M, Stanger BZ, Rustgi AK. Abstract PR04: LIN28B promotes growth and tumorigenesis of the intestinal epithelium primarily via Let-7 repression Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-Pr04 |
0.43 |
|
| 2013 |
Takano S, Reichert M, Heeg S, Bakir B, Rhim AD, Stanger B, Rustgi AK. 339 The Prrx1 Homeobox Transcription Factor Regulates Invasion and EMT in Pancreatic Cancer Gastroenterology. 144: S-71. DOI: 10.1016/S0016-5085(13)60263-2 |
0.375 |
|
| 2012 |
Zong Y, Stanger BZ. Molecular mechanisms of liver and bile duct development. Wiley Interdisciplinary Reviews. Developmental Biology. 1: 643-55. PMID 23799566 DOI: 10.1002/Wdev.47 |
0.589 |
|
| 2012 |
Villanueva A, Alsinet C, Yanger K, Hoshida Y, Zong Y, Toffanin S, Rodriguez-Carunchio L, Solé M, Thung S, Stanger BZ, Llovet JM. Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology. 143: 1660-1669.e7. PMID 22974708 DOI: 10.1053/J.Gastro.2012.09.002 |
0.627 |
|
| 2012 |
Stanger BZ. Quit your YAPing: a new target for cancer therapy. Genes & Development. 26: 1263-7. PMID 22713867 DOI: 10.1101/Gad.196501.112 |
0.385 |
|
| 2012 |
Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 21: 822-35. PMID 22698406 DOI: 10.1016/J.Ccr.2012.04.025 |
0.438 |
|
| 2012 |
Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD, Stanger BZ. EMT and dissemination precede pancreatic tumor formation. Cell. 148: 349-61. PMID 22265420 DOI: 10.1016/J.Cell.2011.11.025 |
0.475 |
|
| 2012 |
Rhim AD, Aiello NM, Mirek ET, Stanger BZ. Abstract IA5: EMT and dissemination precede pancreatic tumor formation. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-Ia5 |
0.455 |
|
| 2012 |
Kim J, Zaret KS, Hoffman JP, Reichert M, Rhim AD, Stanger BZ, Gumbs A. Abstract B98: Induced pluripotent stem cells from pancreatic ductal adenocarcinoma can recapitulate early developmental stages of cancer. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B98 |
0.438 |
|
| 2012 |
Reichert M, Rustgi AK, Takano S, Burstin JAv, Heeg S, Botta GP, Lee J, Schneider G, Rhim AD, Stanger BZ. Abstract A71: The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A71 |
0.448 |
|
| 2012 |
Stanger BZ. Abstract SY04-02: Reaching escape velocity: Using lineage tracing to study EMT and dissemination in pancreatic cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Sy04-02 |
0.431 |
|
| 2012 |
Rhim AD, Reichert M, Rustgi AK, Stanger B. Mo1189 Inflammation is Sufficient and Required to Elicit EMT, Invasion and Dissemination of Pancreas Cells in a Genetically Engineered Mouse Model of Pancreatic Intraepithelial Neoplasia (PanIN) Gastroenterology. 142: S-617. DOI: 10.1016/S0016-5085(12)62369-5 |
0.375 |
|
| 2011 |
Magenheim J, Klein AM, Stanger BZ, Ashery-Padan R, Sosa-Pineda B, Gu G, Dor Y. Ngn3(+) endocrine progenitor cells control the fate and morphogenesis of pancreatic ductal epithelium. Developmental Biology. 359: 26-36. PMID 21888903 DOI: 10.1016/J.Ydbio.2011.08.006 |
0.456 |
|
| 2011 |
Chu AS, Diaz R, Hui JJ, Yanger K, Zong Y, Alpini G, Stanger BZ, Wells RG. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology (Baltimore, Md.). 53: 1685-95. PMID 21520179 DOI: 10.1002/Hep.24206 |
0.602 |
|
| 2011 |
Yanger K, Stanger BZ. Facultative stem cells in liver and pancreas: fact and fancy. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 240: 521-9. PMID 21312313 DOI: 10.1002/Dvdy.22561 |
0.384 |
|
| 2011 |
Zong Y, Stanger BZ. Molecular mechanisms of bile duct development. The International Journal of Biochemistry & Cell Biology. 43: 257-64. PMID 20601079 DOI: 10.1016/J.Biocel.2010.06.020 |
0.621 |
|
| 2011 |
Alsinet C, Yanger K, Villanueva A, Hoshida Y, Zhong Y, Toffanin S, Cabellos L, Thung S, Stanger BZ, Llovet JM. Abstract 2410: Characterization of Notch as an oncogenic driver in liver Cancer Research. 71: 2410-2410. DOI: 10.1158/1538-7445.Am2011-2410 |
0.384 |
|
| 2011 |
Rhim AD, Stanger B. Epithelial-to-Mesenchymal Transition and Hematogenous Dissemination Precedes Histologic Diagnosis of Cancer in a Genetic Mouse Model of Pancreatic Ductal Adenocarcinoma Gastroenterology. 140: S-162. DOI: 10.1016/S0016-5085(11)60657-4 |
0.357 |
|
| 2010 |
Rhim AD, Stanger BZ. Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways. Progress in Molecular Biology and Translational Science. 97: 41-78. PMID 21074729 DOI: 10.1016/B978-0-12-385233-5.00002-7 |
0.438 |
|
| 2010 |
Pan W, Jin Y, Stanger B, Kiernan AE. Notch signaling is required for the generation of hair cells and supporting cells in the mammalian inner ear. Proceedings of the National Academy of Sciences of the United States of America. 107: 15798-803. PMID 20733081 DOI: 10.1073/Pnas.1003089107 |
0.402 |
|
| 2010 |
Hanlon L, Avila JL, Demarest RM, Troutman S, Allen M, Ratti F, Rustgi AK, Stanger BZ, Radtke F, Adsay V, Long F, Capobianco AJ, Kissil JL. Notch1 functions as a tumor suppressor in a model of K-ras-induced pancreatic ductal adenocarcinoma. Cancer Research. 70: 4280-6. PMID 20484026 DOI: 10.1158/0008-5472.Can-09-4645 |
0.355 |
|
| 2010 |
Stanger BZ. Abstract CN10-02: Notch signaling in the progression of pancreatic cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-Cn10-02 |
0.425 |
|
| 2010 |
Liu J, Kong J, Stanger B, Lynch JP. S1683 Cre-Regulated CDx2 Expression in Colon Cancer Cells Gastroenterology. 138: S-253. DOI: 10.1016/S0016-5085(10)61153-5 |
0.38 |
|
| 2010 |
Rhim AD, Rustgi AK, Stanger B. 406 Paracrine Hedgehog Activation in Myofibroblasts Leads to Reciprocal Dedifferentiation and Proliferation of Pancreatic Intraepithelial Neoplasia (PanIN) Epithelial Cells: Insight Into the Role of Stromal-Epithelial Interactions in Cancer Progression Gastroenterology. 138: S-60. DOI: 10.1016/S0016-5085(10)60274-0 |
0.442 |
|
| 2009 |
Antoniou A, Raynaud P, Cordi S, Zong Y, Tronche F, Stanger BZ, Jacquemin P, Pierreux CE, Clotman F, Lemaigre FP. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology. 136: 2325-33. PMID 19403103 DOI: 10.1053/J.Gastro.2009.02.051 |
0.588 |
|
| 2009 |
Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, Stanger BZ. Notch signaling controls liver development by regulating biliary differentiation. Development (Cambridge, England). 136: 1727-39. PMID 19369401 DOI: 10.1242/Dev.029140 |
0.626 |
|
| 2009 |
Guseh JS, Bores SA, Stanger BZ, Zhou Q, Anderson WJ, Melton DA, Rajagopal J. Notch signaling promotes airway mucous metaplasia and inhibits alveolar development. Development (Cambridge, England). 136: 1751-9. PMID 19369400 DOI: 10.1242/Dev.029249 |
0.402 |
|
| 2009 |
Plentz R, Park JS, Rhim AD, Abravanel D, Hezel AF, Sharma SV, Gurumurthy S, Deshpande V, Kenific C, Settleman J, Majumder PK, Stanger BZ, Bardeesy N. Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology. 136: 1741-9.e6. PMID 19208345 DOI: 10.1053/J.Gastro.2009.01.008 |
0.436 |
|
| 2009 |
Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, Stanger BZ. The role of Notch signaling in the bile duct development Developmental Biology. 331: 513. DOI: 10.1016/J.Ydbio.2009.05.472 |
0.582 |
|
| 2008 |
Zong Y, Panikkar A, Stanger BZ. Notch signaling acts at multiple stages to regulate bile duct morphogenesis Developmental Biology. 319: 505-506. DOI: 10.1016/J.Ydbio.2008.05.137 |
0.577 |
|
| 2007 |
Stanger BZ, Tanaka AJ, Melton DA. Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature. 445: 886-91. PMID 17259975 DOI: 10.1038/Nature05537 |
0.359 |
|
| 2006 |
Xu Y, Wang S, Zhang J, Zhao A, Stanger BZ, Gu G. The fringe molecules induce endocrine differentiation in embryonic endoderm by activating cMyt1/cMyt3. Developmental Biology. 297: 340-9. PMID 16920096 DOI: 10.1016/J.Ydbio.2006.04.456 |
0.429 |
|
| 2006 |
Stanger BZ, Dor Y. Dissecting the cellular origins of pancreatic cancer. Cell Cycle (Georgetown, Tex.). 5: 43-6. PMID 16322695 DOI: 10.4161/Cc.5.1.2291 |
0.473 |
|
| 2005 |
Stanger BZ, Stiles B, Lauwers GY, Bardeesy N, Mendoza M, Wang Y, Greenwood A, Cheng KH, McLaughlin M, Brown D, Depinho RA, Wu H, Melton DA, Dor Y. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell. 8: 185-95. PMID 16169464 DOI: 10.1016/J.Ccr.2005.07.015 |
0.436 |
|
| 2005 |
Stanger BZ, Datar R, Murtaugh LC, Melton DA. Direct regulation of intestinal fate by Notch. Proceedings of the National Academy of Sciences of the United States of America. 102: 12443-8. PMID 16107537 DOI: 10.1073/Pnas.0505690102 |
0.386 |
|
| 2003 |
Murtaugh LC, Stanger BZ, Kwan KM, Melton DA. Notch signaling controls multiple steps of pancreatic differentiation. Proceedings of the National Academy of Sciences of the United States of America. 100: 14920-5. PMID 14657333 DOI: 10.1073/Pnas.2436557100 |
0.439 |
|
| 1998 |
Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity. 8: 297-303. PMID 9529147 DOI: 10.1016/S1074-7613(00)80535-X |
0.336 |
|
| 1996 |
Stanger BZ. Looking beneath the surface: The cell death pathway of Fas/APO-1 (CD95) Molecular Medicine. 2: 7-20. PMID 8900530 DOI: 10.1007/Bf03402198 |
0.355 |
|
| 1996 |
Grimm S, Stanger BZ, Leder P. RIP and FADD: two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proceedings of the National Academy of Sciences of the United States of America. 93: 10923-7. PMID 8855284 DOI: 10.1073/Pnas.93.20.10923 |
0.306 |
|
| 1995 |
Rothstein TL, Wang JKM, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju ST, Marshak-Rothstein A. Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells Nature. 374: 163-165. PMID 7533263 DOI: 10.1038/374163A0 |
0.308 |
|
| 1995 |
Ju ST, Panka DJ, Cui H, Ettinger R, Ei-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation Nature. 373: 444-448. PMID 7530337 DOI: 10.1038/373444A0 |
0.321 |
|
| 1989 |
Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, Kefford RF. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 86: 4614-8. PMID 2734311 DOI: 10.1073/Pnas.86.12.4614 |
0.341 |
|
| Show low-probability matches. |